Why brain-to-spine nerve cells lose their ability to regrow during development

Molecular regulation over the decline in long-distance corticospinal axon regenerative ability during development

NIH-funded research Winifred Masterson Burke Med Res Inst · NIH-11235125

This work looks at why the brain-to-spine nerve cells that control movement lose their ability to regrow as we develop, with the goal of helping people with ALS, spinal cord injury, or stroke.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWinifred Masterson Burke Med Res Inst NIH-funded
Lab location1 site (White Plains, United States)
Project IDNIH-11235125 on NIH RePORTER

What this research studies

Researchers will use a new microsurgical method to cut specific corticospinal axons during development without disrupting the surrounding spinal environment, so they can pinpoint when regrowth ability is lost. They will examine molecular signals inside the neurons and in nearby support cells at different developmental stages to see which changes shut down long-distance regrowth. The team will trace axon extension from the cortex to the spinal cord in experimental models and compare responses after early-life versus later lesions. The aim is to identify molecular targets that could guide future therapies to restore long-distance nerve repair.

Who could benefit from this research

Good fit: This is a lab-based, developmental neuroscience project that does not enroll patients now, though future clinical trials informed by these findings might target people with ALS, spinal cord injury, or stroke.

Not a fit: People should not expect direct personal benefit from this basic research, since it focuses on early-stage mechanisms in experimental models rather than current treatments.

Why it matters

Potential benefit: If successful, this work could reveal drug or gene targets that help restore long-distance spinal connections and improve recovery after ALS, spinal cord injury, or stroke.

How similar studies have performed: Prior neonatal lesion models showed greater early-life regenerative ability but disrupted the spinal environment, and this microsurgical approach is a novel way to study when and why regrowth is lost.

Where this research is happening

White Plains, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Amyotrophic Lateral Sclerosis Motor Neuron Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.